A giant Lymphangioma circumscriptum on the flank: Case report

Lymphangioma circumscriptum of the vulva: a review of the literature

Introduction: Lymphangioma circumscriptum (LC) is characterized by malformation of superficial lymphatics. Dermoscopy reveals brownish-yellow lacunae and white septa. In scrotal LC, gray and red areas are also noted. Treatment of LC is challenging because of its high recurrence. We herein report a case of scrotal LC that was successfully treated with topical sirolimus with dermoscopic assessment of the therapeutic response. Case presentation: A male patient presented with fluid-filled lesions on the scrotum after partial penectomy. Examination revealed multiple skin-colored vesicles containing serous fluid on either side of the scrotum. Dermoscopy showed brownish-yellow lacunae with white septa as specific patterns. A diagnosis of secondary LC was made based on the clinical and dermoscopic features, and the patient was treated with 0.1% topical sirolimus ointment. Discussion: Management of LC includes close follow-up. Sirolimus, by inhibiting cellular proliferation and angiogenesis, helps in the regression of vesicular lesions of LC. Furthermore, dermoscopy supports an accurate evaluation of the therapeutic response. Conclusion: Sirolimus is a promising topical agent in the treatment of LC. Dermoscopy comes handy in the evaluation of treatment response. Any residual lesions could be noted and treated accordingly.

Surgical Resection of Acquired Vulvar Lymphangioma Circumscriptum

Patient: Female, 13-year-oldFinal Diagnosis: Lymphangioma circumscriptumSymptoms: Multiple, reddish and pigmented papules located in medial scapular regionClinical Procedure: Combined laser approach (Erbium: Glass and CO2)Specialty: DermatologyObjective: Rare diseaseBackgroundLymphangioma circumscriptum (LC) is a rare condition characterized by a lymphatic malformation primarily affecting the cutaneous region. Although surgical excision has historically been the first-line treatment, it may be associated with substantial complications and recurrence. This case report presents the first documented use of a simultaneous combination of erbium glass (1540 nm) and CO2 (10 600 nm) lasers as a targeted therapeutic strategy for LC in a patient with a dark phototype.Case ReportA previously untreated 13-year-old Asian girl presented with a 5-month history of multiple reddish and pigmented papules located in the right medial scapular region. After histopathological confirmation, the lesions were simultaneously treated with an erbium glass (4.0 W, 1 millisecond, 4 mJ) and CO2 (15 W, 0.25 milliseconds, 3.8 mJ) laser system, followed by topical tacrolimus (0.03%). The protocol was well tolerated, with moderate procedural pain and transient effects that resolved within 2 months. Clinical observation suggested a notable reduction in vesicles, reaching near-total clearance at the 2-month follow-up.ConclusionsThese results suggest that the simultaneous combination of erbium glass and CO2 lasers represents a feasible therapeutic option for LC in patients with pigmented skin. Further investigation in larger studies with extended follow-up is required to establish long-term efficacy and safety compared with conventional surgical or laser-based standards.

Coblation technique as an alternative treatment modality for oral lymphangioma

The lymphangioma is a benign hamartomatous, uncommon, hyperplasia of lymphatic system. It is common in head and neck but rarely found in oral cavity. In oral cavity, it occurs mostly in tongue. In this article,we will report a case of lymphangioma circumscriptum of lip in a young male which is unusual.